Klivira
Request demo

Navigating Medicaid Beovu Prior Authorization

Streamlining Medicaid Beovu prior authorization is critical for ensuring timely patient access to this essential ophthalmic treatment. Klivira automates the complex, state-specific submission processes for Beovu across Medicaid's diverse delivery models.

For revenue cycle and prior authorization teams, managing specialty drug approvals like Beovu within the Medicaid ecosystem presents significant challenges due to its decentralized administration. Varying state-level criteria and the dual nature of Fee-for-Service (FFS) and Managed Care Organization (MCO) models necessitate a robust, adaptive solution to maintain efficiency and minimize denials.

Understanding Beovu in the Medicaid Context

Beovu (brolucizumab) is an anti-VEGF therapy indicated for wet age-related macular degeneration (wet AMD), a leading cause of vision loss. Given its high cost and specialized nature, Beovu is consistently a high-volume prior authorization target across all payer types, including Medicaid managed care plans and state Fee-for-Service programs. Medicaid coverage for Beovu is subject to state-specific formularies, medical necessity criteria, and often includes step therapy requirements or quantity limits.

The Complexities of Medicaid Prior Authorization

Medicaid's structure, encompassing both state-administered Fee-for-Service (FFS) and Managed Care Organizations (MCOs), creates a highly fragmented prior authorization environment. Each state's Medicaid agency and its contracted MCOs maintain distinct medical necessity criteria and submission pathways. This variability impacts the approval process for high-cost specialty medications like Beovu, requiring precise identification of the correct payer entity and adherence to their specific guidelines.

Navigating Beovu Prior Authorization Across Medicaid Models

  • State-Specific Criteria: Beovu coverage and medical necessity requirements vary significantly by state Medicaid agency and individual MCOs.
  • Delivery Model Identification: Accurately determine if the member is covered under a state Fee-for-Service program or a specific Medicaid Managed Care Organization.
  • Payer Portal Diversity: Submissions may require navigating state Medicaid portals for FFS or individual MCO provider portals for managed care plans.
  • X12 278 Utilization: Leverage electronic submission capabilities via X12 278 where supported by the specific state or MCO.
  • CMS-0057-F Impact: Be aware of the phased implementation of FHIR-based Prior Authorization APIs for Medicaid MCOs under CMS-0057-F, which will standardize some electronic processes.

Mitigating Denials for Beovu in Medicaid

Common reasons for Beovu prior authorization denials in Medicaid often stem from incomplete clinical documentation, failure to meet state-specific step therapy protocols, or submission to the incorrect payer entity. Proactive measures include meticulous documentation of diagnosis, previous treatments, and adherence to the precise medical necessity criteria published by the relevant state Medicaid agency or MCO.

Klivira's Solution for Medicaid Beovu Prior Authorization

Klivira integrates with EMRs to automate the submission of Beovu prior authorizations, intelligently routing requests based on the specific Medicaid delivery model and responsible entity. Our platform identifies the applicable state Medicaid agency rules or MCO criteria, ensuring submissions meet the necessary medical necessity requirements and leverage supported electronic channels like X12 278. This approach significantly reduces manual effort and accelerates the approval process for Beovu.

Frequently asked questions

How does Klivira handle the state-by-state variation for Medicaid Beovu prior authorization?

Klivira's system is designed to identify the specific state Medicaid agency or MCO responsible for the patient's coverage. It then applies the correct state-specific medical necessity criteria and routes the Beovu prior authorization request through the appropriate channel, whether it's a state FFS portal or an MCO's provider portal.

What impact does CMS-0057-F have on Beovu prior authorizations for Medicaid patients?

CMS-0057-F mandates phased implementation of FHIR-based Prior Authorization APIs for Medicaid Managed Care Organizations (MCOs), which will streamline electronic PA submissions. While traditional FFS Medicaid is less directly impacted by the API requirements, the rule aims to enhance interoperability across the broader Medicaid landscape, benefiting the efficiency of Beovu PA processes over time.

Can Klivira help with Beovu PA for dual-eligible Medicare and Medicaid patients?

Yes, Klivira's platform supports D-SNP coordination for dual-eligible Medicare and Medicaid members. This ensures that Beovu prior authorization requests account for the complexities of both payer types, helping to navigate coverage requirements effectively for these specific patient populations.

What are the typical channels for submitting Beovu prior authorizations to Medicaid?

Beovu prior authorizations for Medicaid are typically submitted via state Medicaid portals for Fee-for-Service (FFS) beneficiaries or through individual Medicaid Managed Care Organization (MCO) provider portals. Electronic submission via X12 278 is also utilized where supported by the specific state or MCO.

Related coverage

Other beovu prior authorization by payer

Other beovu prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo